Literature DB >> 32522858

Human Cytomegalovirus Utilizes Extracellular Vesicles To Enhance Virus Spread.

Nicholas T Streck1, Yuanjun Zhao2, Jeffrey M Sundstrom2, Nicholas J Buchkovich3.   

Abstract

Human cytomegalovirus (HCMV) manipulates cellular processes associated with secretory pathways within an infected cell to facilitate efficient viral replication. However, little is known about how HCMV infection alters the surrounding cellular environment to promote virus spread to uninfected cells. Extracellular vesicles (EVs) are key signaling molecules that are commonly altered in numerous disease states. Previous reports have shown that viruses commonly alter EVs, which can significantly impact infection. This study finds that HCMV modulates EV biogenesis machinery through upregulation of the endosomal sorting complex required for transport (ESCRT) proteins. This regulation appears to increase the activity of EV biogenesis, since HCMV-infected fibroblasts have increased vesicle release and altered vesicle size compared to EVs from uninfected cells. EVs generated through ESCRT-independent pathways are also beneficial to virus spread in fibroblasts, as treatment with the EV inhibitor GW4869 slowed the efficiency of HCMV spread. Importantly, the transfer of EVs purified from HCMV-infected cells enhanced virus spread. This suggests that HCMV modulates the EV pathway to transfer proviral signals to uninfected cells that prime the cellular environment for incoming infection and enhance the efficiency of virus spread.IMPORTANCE Human cytomegalovirus (HCMV) is a herpesvirus that leads to serious health consequences in neonatal or immunocompromised patients. Clinical management of infection in these at-risk groups remains a serious concern even with approved antiviral therapies available. It is necessary to increase our understanding of the cellular changes that occur during infection and their importance to virus spread. This may help to identify new targets during infection that will lead to the development of novel treatment strategies. Extracellular vesicles (EVs) represent an important method of intercellular communication in the human host. This study finds that HCMV manipulates this pathway to increase the efficiency of virus spread to uninfected cells. This finding defines a new layer of host manipulation induced by HCMV infection that leads to enhanced virus spread.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CD63; ESCRTs; GW4869; HCMV; extracellular vesicles; spread

Mesh:

Year:  2020        PMID: 32522858      PMCID: PMC7394901          DOI: 10.1128/JVI.00609-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells.

Authors:  W A Bresnahan; T E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Production and characterization of monoclonal antibodies specific for a glycosylated polypeptide of human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; C M Chen; K Wisniewski
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

3.  Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.

Authors:  Praneet K Sandhu; Nicholas J Buchkovich
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

4.  Extracellular Vesicles Released by Herpes Simplex Virus 1-Infected Cells Block Virus Replication in Recipient Cells in a STING-Dependent Manner.

Authors:  Thibaut Deschamps; Maria Kalamvoki
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

5.  Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients.

Authors:  T G Wreghitt; S J Abel; K McNeil; J Parameshwar; S Stewart; N Cary; L Sharples; S Large; J Wallwork
Journal:  Transpl Int       Date:  1999       Impact factor: 3.782

6.  A viral microRNA down-regulates multiple cell cycle genes through mRNA 5'UTRs.

Authors:  Finn Grey; Rebecca Tirabassi; Heather Meyers; Guanming Wu; Shannon McWeeney; Lauren Hook; Jay A Nelson
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

7.  Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation.

Authors:  Ritesh Tandon; David P AuCoin; Edward S Mocarski
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

8.  Identification of immediate early gene X-1 as a cellular target gene of hcmv-mir-UL148D.

Authors:  Yue-Ping Wang; Ying Qi; Yu-Jing Huang; Man-Long Qi; Yan-Ping Ma; Rong He; Yao-Hua Ji; Zheng-Rong Sun; Qiang Ruan
Journal:  Int J Mol Med       Date:  2013-02-06       Impact factor: 4.101

9.  Human Cytomegalovirus miR-UL112-3p Targets TLR2 and Modulates the TLR2/IRAK1/NFκB Signaling Pathway.

Authors:  Igor Landais; Chantel Pelton; Daniel Streblow; Victor DeFilippis; Shannon McWeeney; Jay A Nelson
Journal:  PLoS Pathog       Date:  2015-05-08       Impact factor: 6.823

10.  Extracellular vesicles from Kaposi Sarcoma-associated herpesvirus lymphoma induce long-term endothelial cell reprogramming.

Authors:  Ryan P McNamara; Pauline E Chugh; Aubrey Bailey; Lindsey M Costantini; Zhe Ma; Rachele Bigi; Avery Cheves; Anthony B Eason; Justin T Landis; Kurtis M Host; Jie Xiong; Jack D Griffith; Blossom Damania; Dirk P Dittmer
Journal:  PLoS Pathog       Date:  2019-02-04       Impact factor: 6.823

View more
  4 in total

1.  Intermittent bulk release of human cytomegalovirus.

Authors:  Felix J Flomm; Timothy K Soh; Carola Schneider; Linda Wedemann; Hannah M Britt; Konstantinos Thalassinos; Søren Pfitzner; Rudolph Reimer; Kay Grünewald; Jens B Bosse
Journal:  PLoS Pathog       Date:  2022-08-04       Impact factor: 7.464

2.  Human Cytomegalovirus Modifies Placental Small Extracellular Vesicle Composition to Enhance Infection of Fetal Neural Cells In Vitro.

Authors:  Mathilde Bergamelli; Hélène Martin; Yann Aubert; Jean-Michel Mansuy; Marlène Marcellin; Odile Burlet-Schiltz; Ilse Hurbain; Graça Raposo; Jacques Izopet; Thierry Fournier; Alexandra Benchoua; Mélinda Bénard; Marion Groussolles; Géraldine Cartron; Yann Tanguy Le Gac; Nathalie Moinard; Gisela D'Angelo; Cécile E Malnou
Journal:  Viruses       Date:  2022-09-13       Impact factor: 5.818

Review 3.  Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.

Authors:  Carolyn Tallon; Kristen R Hollinger; Arindom Pal; Benjamin J Bell; Rana Rais; Takashi Tsukamoto; Kenneth W Witwer; Norman J Haughey; Barbara S Slusher
Journal:  Drug Discov Today       Date:  2021-03-31       Impact factor: 8.369

4.  MCMV Centrifugal Enhancement: A New Spin on an Old Topic.

Authors:  Trevor J Hancock; Morgan Lynn Hetzel; Andrea Ramirez; Tim E Sparer
Journal:  Pathogens       Date:  2021-12-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.